Stephen Prescott, MD, became the ninth president of the Oklahoma Medical Research Foundation (OMRF) in the spring of 2006. A leader in studies of the basic mechanisms of human disease, Prescott came to OMRF from the University of Utah, where he founded the innovative Eccles Program in Human and Molecular Biology & Genetics and also served as the executive director of the Huntsman Cancer Institute, an NCI-designated cancer center. A native of Texas and an undergraduate at Texas A&M University, Prescott received his MD from the Baylor College of Medicine prior to completing his training in internal medicine at the University of Utah. He then undertook advanced research training at Washington University School of Medicine (St. Louis). In 1982, Prescott joined the faculty of the University of Utah, where he became a professor of internal medicine and held the H.A. & Edna Benning Presidential Endowed Chair. Prescott has consulted for pharmaceutical and biotechnology companies in the United States, Europe, and Japan, and has served on the scientific advisory board or board of directors of four biotechnology companies. He is the founder of LineaGen, a biotechnology company. In 2006, following nomination by President George W. Bush and confirmation by the U.S. Senate, Prescott joined the Board of Trustees for the Udall Foundation.